Ebola vaccines for Guinea and the world

More than 11 000 people in Guinea participated in a WHO-led trial to develop the world’s first vaccine against Ebola virus disease. The ground-breaking trial, which ended in January 2016, resulted in a vaccine that is highly protective against the deadly virus. Dr Margaret Chan, Director-General of WHO, visited some of the communities who participated in the vaccine trial in the city of Conakry.